Cipher's once-daily tramadol approved in US
This article was originally published in Scrip
Executive Summary
The US FDA has approved Cipher Pharmaceuticals' extended-release once-daily formulation of the generic analgesic tramadol, CIP-Tramadol ER, for the treatment of moderate to moderately-severe chronic pain in adults.